RALEIGH, N.C. – LipoScience, Inc. has entered into an agreement with ARUP Laboratories, a national clinical and anatomic pathology laboratory, to offer its proprietary NMR LipoProfile test.
ARUP serves as the primary reference laboratory for more than half of the nation’s university teaching hospitals and children’s hospitals. Through the agreement with ARUP, these hospitals will now have access to the NMR LipoProfile test.
Studies show that 50 percent of the people who had heart attacks had normal cholesterol levels. Based on new research, we understand that heart disease, or blocking of the arteries is caused by lipoproteins. Lipoproteins are containers in the blood that carry cholesterol.
“The NMR LipoProfile test is a tool that identifies patients at risk for heart disease that would normally be missed by traditional cholesterol tests alone and gives clinicians lipoprotein particle information to manage that risk appropriately,” said Ronald L. Weiss, president and COO of ARUP Laboratories in a published statement.
ARUP’s other clients include multihospital groups, major commercial laboratories, group purchasing organizations, military and government facilities, and major clinics.
ARUP Laboratories: www.aruplab.com